a developer of gene-based medicines
Industry Biotechnology
A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.
Ticker / NAME | Correlation To CRSP | 1D Price Change % | ||
---|---|---|---|---|
CRSP | 100% | -1.85% | ||
BEAM - CRSP | 75% Closely correlated | -1.57% | ||
EDIT - CRSP | 64% Loosely correlated | -3.58% | ||
NTLA - CRSP | 64% Loosely correlated | -3.24% | ||
PRME - CRSP | 60% Loosely correlated | -8.33% | ||
RXRX - CRSP | 57% Loosely correlated | -3.43% | ||
More |
Ticker / NAME | Correlation To CRSP | 1D Price Change % |
---|---|---|
CRSP | 100% | -1.85% |
gene-based medicines theme (3 stocks) | 99% Closely correlated | -5.72% |
CRSP theme (4 stocks) | 94% Closely correlated | -5.68% |
drugs theme (254 stocks) | 61% Loosely correlated | -1.72% |
europe theme (179 stocks) | 38% Loosely correlated | -0.25% |
innovating biotech theme (18 stocks) | 38% Loosely correlated | -2.05% |
More |